Translational Digital Pathology & AI Summit 2025

Opis

Najważniejsze punkty

Uniting senior leaders from digital pathology, translational medicine, informatics, biomarker development, and precision medicine. Addressing critical bottlenecks and exciting developments in digital pathology and AI. Exploring AI applications to enhance lab workflows and drug development. Strategies to streamline preclinical and translational drug development. Networking opportunities with industry leaders from Pfizer, AstraZeneca, Novartis, and Gilead. Workshops and discussions on integrating digital pathology for cost-effective advancements. Focus on biomarker discovery, endpoint validation, and patient stratification. Improving pathological data handling and image quality. Aligning with regulatory frameworks for practical applications. Enhancing target identification and validation capabilities.